Setting

Stanford Health Care (SHC) is world-renowned for advanced patient care, particularly for the treatment of cancer. It is recognized by U.S. News & World Report as one of "America's Best Hospitals" and currently ranked #9 in the U.S for cancer. SHC is also a National Cancer Institute (NCI) Designated Cancer Center. Stanford Health Care has a close relationship with both the Stanford University School of Medicine and Lucile Packard Children's Hospital, an adjacent pediatric teaching hospital providing general acute and tertiary care. The hospitals are located on three different sites, the Stanford University campus in Palo Alto, California; it is about 20 miles north of San Jose and about 40 miles south of San Francisco, Redwood City, and San Jose (South Bay).

Mailing Address:

Program Overview

The Hematology/Oncology Residency at Stanford Health Care is a PGY-2 specialty training program that offers extensive hematology and oncology experiences at Stanford Comprehensive Cancer Center, currently ranked top 11 in the nation. One applicant is accepted per year.

The program is designed to transition PGY-1 residency graduates from general practice to specialized practice focused on the care of patients with oncologic and/or hematologic disorders. Residency graduates will be equipped to participate as integral members of interdisciplinary teams, assuming responsibility for pharmaceutical care.

Throughout the program, the resident will gain practical experience in the management in neoplastic diseases as well as cancer-related and cancer treatment-related disorders. Due to the prominent use of investigational drugs in the treatment of cancer, the resident will also gain the knowledge and skills necessary to practice effectively in clinical research environments. They will be able to manage the preparation, distribution, and disposal of hazardous medications in both inpatient and ambulatory settings. Their experience will also include leadership in formulary decision-making for cancer-related medications.

Groomed for practice leadership, the PGY-2 Hematology/Oncology resident will be able to successfully serve health-care organizations with the clinical and practice skills necessary for effective decision-making in the treatment of oncologic and hematologic disorders.

Program Goals

The goal of the PGY-2 Hematology/Oncology Residency Program is to provide a broad experience-based foundation in hematology/oncology, to develop his/her clinical skills, and to prepare for a comprehensive clinical practice in hematology/oncology.

Program Structure

The Hematology/Oncology Specialty Residency is accredited by the American Society of Health System Pharmacists (ASHP). The program follows the ASHP Residency Learning System (RLS) and its goals and learning objectives are consistent with standards developed by ASHP.

Compensation & Benefits

PGY-2 residents receive a competitive annual stipend of approximately $84,000 with full benefits, including an excellent health-care benefits package and 10 days paid time off. In addition, the PGY-2 resident will enjoy educational leave and a stipend to attend and participate at various pharmacy conferences throughout the year.

For consideration, the online application and all supporting documentation must be received by Monday, December 31, 2018. Early submission is helpful.

On-Site Interview

After all application materials have been reviewed, selected applicants will be contacted for a half-day on-site interview to be conducted in February 2019. The date of the interview is negotiable based on candidate and interview panel schedules. The candidate is required to give a 15 minute Powerpoint presentation on any pharmacy-related topic (oncology topic preferred).

Interviews will be conducted in February 2019.

Application Deadline

The application deadline is Monday, December 31, 2018.

NO applications will be accepted beyond this date.

Eligibility

Participation in our Hematology/Oncology Specialty Residency Program requires a Pharm.D. degree from an ACPE-accredited College or School of Pharmacy and completion of an ASHP-accredited PGY-1 residency. Out of state candidates must obtain a California Intern license prior to the first day of residency and California Pharmacist licensure must be obtained within 3 months of start date of residency.

The Department of Pharmacy provides integrated, cost-effective pharmaceutical services to Stanford Health Care (SHC). These patient-focused services include medication delivery, therapeutic recommendations, and promotion of optimal drug therapy.
To advance its mission, the department provides a supportive environment for professional training and development. The Department of Pharmacy participates in the American Society of Health-System Pharmacists (ASHP) Residency program. Four ASHP-accredited residency training programs are offered including a PGY-1 pharmacy practice residency (one with an ambulatory care focus), and two specialty PGY-2 residencies in Critical Care and Oncology/Hematology.

BACK TO TOP

Help is on the way!

We're sorry you are having trouble applying for this job.

Please try loading this job using the following link before submitting your help request:

Name:Email:

Please provide details:

Error

Powered By

You do not have JavaScript Enabled on this browser.
Please enable it
in order to use the full functionality of our website.